PRDM14 was positively correlated with sensitivity to small-molecule drugs such as TPCA-1, PF-56,227, mirin, and linsitinib.<h4>Conclusions</h4>Collectively, our findings suggest that PRDM14 is a positive regulator of gastric cancer progression. The gene discussed is PRDM14; the disease is gastric cancer.